Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å...

書誌詳細
主要な著者:	Kim, H, Tan, L, Weisberg, E, Liu, F, Canning, P, Choi, H, Ezell, SA, Wu, H, Zhao, Z, Wang, J, Mandinova, A, Griffin, J, Bullock, A, Liu, Q, Lee, S, Gray, N
フォーマット:	Journal article
言語:	English
出版事項:	2013

類似資料

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
著者:: Kim, H, 等
出版事項: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors
著者:: Canning, P, 等
出版事項: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
著者:: Canning, P, 等
出版事項: (2014)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
著者:: Maria G. Nava, 等
出版事項: (2023-02-01)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
著者:: López-Ramos, M, 等
出版事項: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
著者:: López-Ramos, M, 等
出版事項: (2010)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
著者:: William A. Denny, 等
出版事項: (2021-11-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
著者:: Panupong Mahalapbutr, 等
出版事項: (2024-02-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
著者:: Ronnakorn Leechaisit, 等
出版事項: (2023-08-01)

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
著者:: Patrice Dubreuil, 等
出版事項: (2009-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
著者:: Xu H, 等
出版事項: (2019-07-01)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
著者:: Sudarshan R Iyer, 等
出版事項: (2023-10-01)

Recent Advances in Discovery of New Tyrosine Kinase Inhibitors Using Computational Methods
著者:: Vesna Rastija
出版事項: (2019-08-01)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
著者:: Chunmin Yang, 等
出版事項: (2022-05-01)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
著者:: Hellwig, S, 等
出版事項: (2012)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
著者:: Lopez-Ramos, M, 等
出版事項: (2011)

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
著者:: C. Reger de Moura, 等
出版事項: (2024-01-01)

Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
著者:: Ellen Weisberg, 等
出版事項: (2013-01-01)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
著者:: Ian M. Catlett, 等
出版事項: (2023-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
著者:: Maria Dimou, 等
出版事項: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
著者:: Elisabetta Abruzzese, 等
出版事項: (2014-04-01)

Second-generation inhibitors of Bruton tyrosine kinase
著者:: Jingjing Wu, 等
出版事項: (2016-09-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
著者:: Cornelius Hempel, 等
出版事項: (2017-01-01)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
著者:: Yangyang Yao, 等
出版事項: (2017-10-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
著者:: John J. Ryan, MD
出版事項: (2016-12-01)

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
著者:: Zhao, Z, 等
出版事項: (2014)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
著者:: Ainun Nizar Masbuchin, 等
出版事項: (2022-09-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
著者:: G. V. Lukina, 等
出版事項: (2015-12-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
著者:: Huang JT, 等
出版事項: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
著者:: Mark C Weir, 等
出版事項: (2017-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
著者:: Tatsuki Shibuta, 等
出版事項: (2022-06-01)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
著者:: Chris Liang, 等
出版事項: (2022-03-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
著者:: Jiangnan Liu, 等
出版事項: (2024-03-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
著者:: Wu J, 等
出版事項: (2020-09-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
著者:: Muhammad Waleed Iqbal, 等
出版事項: (2025-01-01)

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
著者:: Pitsiou G, 等
出版事項: (2014-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
著者:: Matthew Walters, 等
出版事項: (2020-11-01)

Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma
著者:: Wei Dai, 等
出版事項: (2021-05-01)

Tetrahydroisoquinoline-7-carboxamide derivatives as new selective discoidin domain receptor 1 (DDR1) inhibitors
著者:: Bullock, A, 等
出版事項: (2017)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
著者:: Evan Pisick, 等
出版事項: (2004-01-01)